Article
26 Jan 2026
A Relaxing 2026? FDA Updates General Wellness And Clinical Decision Support Software Guidance
AUTHORS CONTENT
Article
23 Dec 2025
FDA Drives Digital Health Forward With Pilot Program For Chronic Condition Devices
Article
09 Dec 2025
FDA's Biosimilar Playbook: Merging Biosimilarity With Interchangeability
Article
06 Nov 2025
FDA Proposes To Remove Comparative Efficacy Studies To Accelerate Biosimilar Development
Article
31 Jul 2025
Congress Expands Orphan Drug Exemptions From Medicare Price Negotiations
Article
17 Jun 2025
Medicare's Innovation Center Charts New Direction: Part 3 – Drugs, Devices, And Data
Article
01 May 2025
Judge Blocks FDA Regulation Of Laboratory-Developed Tests
Article
02 Apr 2025
Proposed California Legislation Aims To Phase Out Ultra-Processed Foods From School Meals
Article
27 Mar 2025
FDA Directed To Explore Elimination Of Food Additive "Loophole"
Article
05 Feb 2025
CMS's New TCET Pathway Expedites Medicare Coverage For FDA Breakthrough Devices
Article
07 Jan 2025
FDA's Digital Health Advisory Committee Discusses Total Product Lifecycle Considerations For GenAI-Enabled Devices
Article
06 Jan 2025
FDA's Final Guidance Provides Practical Approach For AI-Enabled Devices Implementing Post-Market Modifications
Article
14 Nov 2024
Inaugural Meeting For FDA's Digital Health Advisory Committee To Focus On GenAI-Enabled Medical Devices
Article
11 Nov 2024
FDA's New Human Foods Program: Enhancing Post-Market Safety Assessments Of Chemicals In Food
Article
15 Aug 2024
FDA Remote Regulatory Assessments Are Not So Remote Anymore
Article
19 Jun 2024
FDA Launches The Center For Clinical Trial Innovation
Article
31 May 2024
NIH Seeks Comments On Patient Access Plan Requirements In Patent License Agreements
Article
28 May 2024
Canadian Drug Importation May Undermine Intellectual Property Protection
Article
08 May 2024
FTC Weighs In On Orange Book Listing Of Drug-Device Patents
Article
30 Apr 2024
FDA Proposes Updated Guidance Concerning Cybersecurity Of Medical Devices